Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Giaccone

Showing results (81-90 of 380) with videos related to

Pageof 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Personalizing therapy in an epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer using PF-00299804 and trastuzumabRonan J Kelly, Corey Carter, Giuseppe Giaccone
The Oncologist|April 17, 2003
Signal transduction modulators for cancer therapy: from promise to practice?Marinus W Lobbezoo, Giuseppe Giaccone, Coenraad Van Kalken, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
"Pseudocavitation" in thymic carcinoma during treatment with sunitinibMarcello Tiseo, Arun Rajan, Anish Thomas, et al.
Expert Opinion on Investigational Drugs|November 27, 2009
Small-molecule inhibitors of the human epidermal receptor familyCorey A Carter, Ronan J Kelly, Giuseppe Giaccone
Clinical Lung Cancer|July 16, 2010
Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic realityRonan J Kelly, James L Gulley, Giuseppe Giaccone
Nature Reviews. Cancer|July 24, 2010
Targeting the dynamic HSP90 complex in cancerJane Trepel, Mehdi Mollapour, Giuseppe Giaccone, et al.
Discovery Medicine|May 28, 2016
Novel approaches in cancer immunotherapyDeepa S Subramaniam, Stephen V Liu, Giuseppe Giaccone
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2009
The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancerAriel Lopez-Chavez, Corey A Carter, Giuseppe Giaccone
Expert Opinion on Investigational Drugs|December 7, 2016
Ganetespib for small cell lung cancerDeepa S Subramaniam, Eiran A Warner, Giuseppe Giaccone
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
Multiorgan autoimmune manifestations associated with thymomaAnish Thomas, Arun Rajan, Arlene Berman, et al.
Pageof 38

Showing results (81-90 of 380) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Personalizing therapy in an epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer using PF-00299804 and trastuzumabRonan J Kelly, Corey Carter, Giuseppe Giaccone
The Oncologist|April 17, 2003
Signal transduction modulators for cancer therapy: from promise to practice?Marinus W Lobbezoo, Giuseppe Giaccone, Coenraad Van Kalken, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
"Pseudocavitation" in thymic carcinoma during treatment with sunitinibMarcello Tiseo, Arun Rajan, Anish Thomas, et al.
Expert Opinion on Investigational Drugs|November 27, 2009
Small-molecule inhibitors of the human epidermal receptor familyCorey A Carter, Ronan J Kelly, Giuseppe Giaccone
Clinical Lung Cancer|July 16, 2010
Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic realityRonan J Kelly, James L Gulley, Giuseppe Giaccone
Nature Reviews. Cancer|July 24, 2010
Targeting the dynamic HSP90 complex in cancerJane Trepel, Mehdi Mollapour, Giuseppe Giaccone, et al.
Discovery Medicine|May 28, 2016
Novel approaches in cancer immunotherapyDeepa S Subramaniam, Stephen V Liu, Giuseppe Giaccone
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2009
The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancerAriel Lopez-Chavez, Corey A Carter, Giuseppe Giaccone
Expert Opinion on Investigational Drugs|December 7, 2016
Ganetespib for small cell lung cancerDeepa S Subramaniam, Eiran A Warner, Giuseppe Giaccone
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
Multiorgan autoimmune manifestations associated with thymomaAnish Thomas, Arun Rajan, Arlene Berman, et al.
Pageof 38